Neurological update: COVID-19
Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neu...
Gespeichert in:
| Veröffentlicht in: | Journal of neurology 2021-11, Vol.268 (11), p.4379-4387 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4387 |
|---|---|
| container_issue | 11 |
| container_start_page | 4379 |
| container_title | Journal of neurology |
| container_volume | 268 |
| creator | Ren, A. L. Digby, R. J. Needham, E. J. |
| description | Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. It is still unclear whether direct invasion of the nervous system by the Severe Acute Respiratory Syndrome Coronavirus 2 occurs; given the vast numbers of people infected at this point, this uncertainty suggests that nervous system infection is unlikely to represent a significant issue if it occurs at all. In this review, we explore what has been learnt about the neurological complications of COVID-19 over the course of the pandemic, and by which mechanisms these complications most commonly occur. |
| doi_str_mv | 10.1007/s00415-021-10581-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8085652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2580827339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-7598b2f1d43a722f711809ef44942b37365dc2599251acb281628c3d80d8e2553</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotl5eQFAEN26iJydJk7gQpN4KRTfqNqQzmTplOlOTjtC3N9p6XbjK4v_Of3I-QvYYnDAAdRoBBJMUkFEGUjO6WCNdJjhSJqRZJ13gAqjkUnTIVowTANAp2CQdzg2aHlNdsn_n29BUzbjMXHXYznI392eH_funwSVlZodsFK6Kfnf1bpPH66uH_i0d3t8M-hdDmgkl5lRJo0dYsFxwpxALxZgG4wshjMARV7wn8wylMSiZy0aoWQ91xnMNufYoJd8m58veWTua-jzz9Ty4ys5COXVhYRtX2t9JXT7bcfNqNWjZk5gKjlcFoXlpfZzbaRkzX1Wu9k0bLUoErTgIkdCjP-ikaUOdzktU6kOV7CQKl1QWmhiDL74-w8C-27dL-zbZtx_27SINHfw842vkU3cC-BKIKarHPnzv_qf2DXvMjKw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580827339</pqid></control><display><type>article</type><title>Neurological update: COVID-19</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Ren, A. L. ; Digby, R. J. ; Needham, E. J.</creator><creatorcontrib>Ren, A. L. ; Digby, R. J. ; Needham, E. J.</creatorcontrib><description>Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. It is still unclear whether direct invasion of the nervous system by the Severe Acute Respiratory Syndrome Coronavirus 2 occurs; given the vast numbers of people infected at this point, this uncertainty suggests that nervous system infection is unlikely to represent a significant issue if it occurs at all. In this review, we explore what has been learnt about the neurological complications of COVID-19 over the course of the pandemic, and by which mechanisms these complications most commonly occur.</description><identifier>ISSN: 0340-5354</identifier><identifier>EISSN: 1432-1459</identifier><identifier>DOI: 10.1007/s00415-021-10581-y</identifier><identifier>PMID: 33929617</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cerebrovascular diseases ; Cerebrovascular Disorders ; Coronaviruses ; COVID-19 ; Humans ; Medicine ; Medicine & Public Health ; Nervous system ; Nervous System Diseases - epidemiology ; Nervous System Diseases - etiology ; Neurological complications ; Neurological diseases ; Neurological Update ; Neurology ; Neuroradiology ; Neurosciences ; Pandemics ; Respiratory system ; SARS-CoV-2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Journal of neurology, 2021-11, Vol.268 (11), p.4379-4387</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-7598b2f1d43a722f711809ef44942b37365dc2599251acb281628c3d80d8e2553</citedby><cites>FETCH-LOGICAL-c474t-7598b2f1d43a722f711809ef44942b37365dc2599251acb281628c3d80d8e2553</cites><orcidid>0000-0001-7042-7462</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00415-021-10581-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00415-021-10581-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33929617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ren, A. L.</creatorcontrib><creatorcontrib>Digby, R. J.</creatorcontrib><creatorcontrib>Needham, E. J.</creatorcontrib><title>Neurological update: COVID-19</title><title>Journal of neurology</title><addtitle>J Neurol</addtitle><addtitle>J Neurol</addtitle><description>Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. It is still unclear whether direct invasion of the nervous system by the Severe Acute Respiratory Syndrome Coronavirus 2 occurs; given the vast numbers of people infected at this point, this uncertainty suggests that nervous system infection is unlikely to represent a significant issue if it occurs at all. In this review, we explore what has been learnt about the neurological complications of COVID-19 over the course of the pandemic, and by which mechanisms these complications most commonly occur.</description><subject>Cerebrovascular diseases</subject><subject>Cerebrovascular Disorders</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nervous system</subject><subject>Nervous System Diseases - epidemiology</subject><subject>Nervous System Diseases - etiology</subject><subject>Neurological complications</subject><subject>Neurological diseases</subject><subject>Neurological Update</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Pandemics</subject><subject>Respiratory system</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0340-5354</issn><issn>1432-1459</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kMtKAzEUhoMotl5eQFAEN26iJydJk7gQpN4KRTfqNqQzmTplOlOTjtC3N9p6XbjK4v_Of3I-QvYYnDAAdRoBBJMUkFEGUjO6WCNdJjhSJqRZJ13gAqjkUnTIVowTANAp2CQdzg2aHlNdsn_n29BUzbjMXHXYznI392eH_funwSVlZodsFK6Kfnf1bpPH66uH_i0d3t8M-hdDmgkl5lRJo0dYsFxwpxALxZgG4wshjMARV7wn8wylMSiZy0aoWQ91xnMNufYoJd8m58veWTua-jzz9Ty4ys5COXVhYRtX2t9JXT7bcfNqNWjZk5gKjlcFoXlpfZzbaRkzX1Wu9k0bLUoErTgIkdCjP-ikaUOdzktU6kOV7CQKl1QWmhiDL74-w8C-27dL-zbZtx_27SINHfw842vkU3cC-BKIKarHPnzv_qf2DXvMjKw</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Ren, A. L.</creator><creator>Digby, R. J.</creator><creator>Needham, E. J.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7042-7462</orcidid></search><sort><creationdate>20211101</creationdate><title>Neurological update: COVID-19</title><author>Ren, A. L. ; Digby, R. J. ; Needham, E. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-7598b2f1d43a722f711809ef44942b37365dc2599251acb281628c3d80d8e2553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cerebrovascular diseases</topic><topic>Cerebrovascular Disorders</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nervous system</topic><topic>Nervous System Diseases - epidemiology</topic><topic>Nervous System Diseases - etiology</topic><topic>Neurological complications</topic><topic>Neurological diseases</topic><topic>Neurological Update</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Pandemics</topic><topic>Respiratory system</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, A. L.</creatorcontrib><creatorcontrib>Digby, R. J.</creatorcontrib><creatorcontrib>Needham, E. J.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, A. L.</au><au>Digby, R. J.</au><au>Needham, E. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurological update: COVID-19</atitle><jtitle>Journal of neurology</jtitle><stitle>J Neurol</stitle><addtitle>J Neurol</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>268</volume><issue>11</issue><spage>4379</spage><epage>4387</epage><pages>4379-4387</pages><issn>0340-5354</issn><eissn>1432-1459</eissn><abstract>Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. It is still unclear whether direct invasion of the nervous system by the Severe Acute Respiratory Syndrome Coronavirus 2 occurs; given the vast numbers of people infected at this point, this uncertainty suggests that nervous system infection is unlikely to represent a significant issue if it occurs at all. In this review, we explore what has been learnt about the neurological complications of COVID-19 over the course of the pandemic, and by which mechanisms these complications most commonly occur.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33929617</pmid><doi>10.1007/s00415-021-10581-y</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7042-7462</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-5354 |
| ispartof | Journal of neurology, 2021-11, Vol.268 (11), p.4379-4387 |
| issn | 0340-5354 1432-1459 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8085652 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Cerebrovascular diseases Cerebrovascular Disorders Coronaviruses COVID-19 Humans Medicine Medicine & Public Health Nervous system Nervous System Diseases - epidemiology Nervous System Diseases - etiology Neurological complications Neurological diseases Neurological Update Neurology Neuroradiology Neurosciences Pandemics Respiratory system SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 |
| title | Neurological update: COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T16%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurological%20update:%20COVID-19&rft.jtitle=Journal%20of%20neurology&rft.au=Ren,%20A.%20L.&rft.date=2021-11-01&rft.volume=268&rft.issue=11&rft.spage=4379&rft.epage=4387&rft.pages=4379-4387&rft.issn=0340-5354&rft.eissn=1432-1459&rft_id=info:doi/10.1007/s00415-021-10581-y&rft_dat=%3Cproquest_pubme%3E2580827339%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2580827339&rft_id=info:pmid/33929617&rfr_iscdi=true |